Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease

Yoshikuni Mizuno, Nobuo Yanagisawa, Sadako Kuno, Mitsutoshi Yamamoto, Kazuko Hasegawa, Hideki Origasa, Hisayuki Kowa, M. Tamaki, S. Simojyo, S. Koh, T. Maruyama, T. Kachi, M. Takahashi, T. Hazama, T. Matsubara, J. Kawamura, K. Hiyama, T. Nakamuro, T. Kondo, K. NakajimaKoji Abe, Y. Sunada, T. Tuji, J. Yoshinaga, N. Yamashita, T. Yamada, H. Fukunaga, F. Moriwaka, M. Baba, I. Toyoshima, T. Abe, T. Yamamoto, K. Yamane, F. Yokochi, S. Nogawa, T. Simizu, M. Murata, Y. Mizuno, H. Oka

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment.

Original languageEnglish
Pages (from-to)1149-1156
Number of pages8
JournalMovement Disorders
Volume18
Issue number10
DOIs
Publication statusPublished - Oct 2003

Fingerprint

Bromocriptine
Double-Blind Method
Parkinson Disease
Placebos
Levodopa
Safety
Therapeutics
pramipexole

Keywords

  • Bromocriptine
  • Drug comparison
  • Levodopa
  • Parkinson's disease
  • Pramipexole
  • Randomized controlled trial (RCT)

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Mizuno, Y., Yanagisawa, N., Kuno, S., Yamamoto, M., Hasegawa, K., Origasa, H., ... Oka, H. (2003). Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. Movement Disorders, 18(10), 1149-1156. https://doi.org/10.1002/mds.10508

Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. / Mizuno, Yoshikuni; Yanagisawa, Nobuo; Kuno, Sadako; Yamamoto, Mitsutoshi; Hasegawa, Kazuko; Origasa, Hideki; Kowa, Hisayuki; Tamaki, M.; Simojyo, S.; Koh, S.; Maruyama, T.; Kachi, T.; Takahashi, M.; Hazama, T.; Matsubara, T.; Kawamura, J.; Hiyama, K.; Nakamuro, T.; Kondo, T.; Nakajima, K.; Abe, Koji; Sunada, Y.; Tuji, T.; Yoshinaga, J.; Yamashita, N.; Yamada, T.; Fukunaga, H.; Moriwaka, F.; Baba, M.; Toyoshima, I.; Abe, T.; Yamamoto, T.; Yamane, K.; Yokochi, F.; Nogawa, S.; Simizu, T.; Murata, M.; Mizuno, Y.; Oka, H.

In: Movement Disorders, Vol. 18, No. 10, 10.2003, p. 1149-1156.

Research output: Contribution to journalArticle

Mizuno, Y, Yanagisawa, N, Kuno, S, Yamamoto, M, Hasegawa, K, Origasa, H, Kowa, H, Tamaki, M, Simojyo, S, Koh, S, Maruyama, T, Kachi, T, Takahashi, M, Hazama, T, Matsubara, T, Kawamura, J, Hiyama, K, Nakamuro, T, Kondo, T, Nakajima, K, Abe, K, Sunada, Y, Tuji, T, Yoshinaga, J, Yamashita, N, Yamada, T, Fukunaga, H, Moriwaka, F, Baba, M, Toyoshima, I, Abe, T, Yamamoto, T, Yamane, K, Yokochi, F, Nogawa, S, Simizu, T, Murata, M, Mizuno, Y & Oka, H 2003, 'Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease', Movement Disorders, vol. 18, no. 10, pp. 1149-1156. https://doi.org/10.1002/mds.10508
Mizuno, Yoshikuni ; Yanagisawa, Nobuo ; Kuno, Sadako ; Yamamoto, Mitsutoshi ; Hasegawa, Kazuko ; Origasa, Hideki ; Kowa, Hisayuki ; Tamaki, M. ; Simojyo, S. ; Koh, S. ; Maruyama, T. ; Kachi, T. ; Takahashi, M. ; Hazama, T. ; Matsubara, T. ; Kawamura, J. ; Hiyama, K. ; Nakamuro, T. ; Kondo, T. ; Nakajima, K. ; Abe, Koji ; Sunada, Y. ; Tuji, T. ; Yoshinaga, J. ; Yamashita, N. ; Yamada, T. ; Fukunaga, H. ; Moriwaka, F. ; Baba, M. ; Toyoshima, I. ; Abe, T. ; Yamamoto, T. ; Yamane, K. ; Yokochi, F. ; Nogawa, S. ; Simizu, T. ; Murata, M. ; Mizuno, Y. ; Oka, H. / Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. In: Movement Disorders. 2003 ; Vol. 18, No. 10. pp. 1149-1156.
@article{557b331a44af4130928cb07387fd3864,
title = "Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease",
abstract = "We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment.",
keywords = "Bromocriptine, Drug comparison, Levodopa, Parkinson's disease, Pramipexole, Randomized controlled trial (RCT)",
author = "Yoshikuni Mizuno and Nobuo Yanagisawa and Sadako Kuno and Mitsutoshi Yamamoto and Kazuko Hasegawa and Hideki Origasa and Hisayuki Kowa and M. Tamaki and S. Simojyo and S. Koh and T. Maruyama and T. Kachi and M. Takahashi and T. Hazama and T. Matsubara and J. Kawamura and K. Hiyama and T. Nakamuro and T. Kondo and K. Nakajima and Koji Abe and Y. Sunada and T. Tuji and J. Yoshinaga and N. Yamashita and T. Yamada and H. Fukunaga and F. Moriwaka and M. Baba and I. Toyoshima and T. Abe and T. Yamamoto and K. Yamane and F. Yokochi and S. Nogawa and T. Simizu and M. Murata and Y. Mizuno and H. Oka",
year = "2003",
month = "10",
doi = "10.1002/mds.10508",
language = "English",
volume = "18",
pages = "1149--1156",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease

AU - Mizuno, Yoshikuni

AU - Yanagisawa, Nobuo

AU - Kuno, Sadako

AU - Yamamoto, Mitsutoshi

AU - Hasegawa, Kazuko

AU - Origasa, Hideki

AU - Kowa, Hisayuki

AU - Tamaki, M.

AU - Simojyo, S.

AU - Koh, S.

AU - Maruyama, T.

AU - Kachi, T.

AU - Takahashi, M.

AU - Hazama, T.

AU - Matsubara, T.

AU - Kawamura, J.

AU - Hiyama, K.

AU - Nakamuro, T.

AU - Kondo, T.

AU - Nakajima, K.

AU - Abe, Koji

AU - Sunada, Y.

AU - Tuji, T.

AU - Yoshinaga, J.

AU - Yamashita, N.

AU - Yamada, T.

AU - Fukunaga, H.

AU - Moriwaka, F.

AU - Baba, M.

AU - Toyoshima, I.

AU - Abe, T.

AU - Yamamoto, T.

AU - Yamane, K.

AU - Yokochi, F.

AU - Nogawa, S.

AU - Simizu, T.

AU - Murata, M.

AU - Mizuno, Y.

AU - Oka, H.

PY - 2003/10

Y1 - 2003/10

N2 - We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment.

AB - We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment.

KW - Bromocriptine

KW - Drug comparison

KW - Levodopa

KW - Parkinson's disease

KW - Pramipexole

KW - Randomized controlled trial (RCT)

UR - http://www.scopus.com/inward/record.url?scp=10744224334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744224334&partnerID=8YFLogxK

U2 - 10.1002/mds.10508

DO - 10.1002/mds.10508

M3 - Article

C2 - 14534919

AN - SCOPUS:10744224334

VL - 18

SP - 1149

EP - 1156

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 10

ER -